Last updated: August 20, 2025
Introduction
Patent KR20170085604, filed by a South Korean innovator, pertains to a pharmaceutical invention designed to improve therapeutic modalities, likely within the burgeoning domain of medical treatments involving drug delivery systems or novel compound formulations. This patent's scope, claims, and landscape analysis reveal its strategic significance in South Korea’s intellectual property ecosystem, emphasizing innovation in medicine and biotech sectors.
Scope of Patent KR20170085604
The scope of KR20170085604 primarily centers around a specific pharmaceutical compound, formulation, or delivery mechanism that offers an improved therapeutic profile. The patent aims to secure exclusive rights to methods of manufacturing, administering, or utilizing the invention. Its scope likely encompasses:
- Chemical Composition: Novel chemical entities or derivatives with unique pharmacodynamic properties.
- Formulation Methods: Specific pharmaceutical formulations (e.g., sustained release, targeted delivery).
- Therapeutic Use: Claims cover indications such as cancer, infectious diseases, or chronic conditions, depending on the disclosed compound.
- Delivery Systems: Encompasses devices or formulations that enhance bioavailability, stability, or patient compliance.
The scope may be constrained by prior art references, emphasizing inventive steps over conventional compounds or methods.
Claims Analysis
The claims define the legal boundary of the patent. A typical set of claims in such patents involves independent claims covering core inventions followed by dependent claims detailing specific embodiments or improvements.
1. Independent Claims
- Composition Claims: Likely claims on a compound with specific structural features, such as a novel molecular scaffold or functional groups providing unique activity.
- Method Claims: Techniques for synthesizing the compound, or administering it to a patient.
- Use Claims: Therapeutic applications, such as treating specific diseases with the compound.
2. Dependent Claims
- Variations of the core compound, e.g., modifications of functional groups that enhance stability or potency.
- Specific dosage forms, such as tablets, injections, or transdermal patches.
- Combination claims involving the invention with other pharmacologically active agents.
- Claims related to manufacturing processes optimizing yield, purity, or cost-effectiveness.
Innovative Aspects and Claim Breadth
The patent likely emphasizes inventive benefits such as increased efficacy, reduced toxicity, or simplified synthesis pathways. The breadth of claims will aim to cover avoided prior art, ensuring robust infringement protection but balanced against the requirement for novelty and inventive step under Korean patent law.
Patent Landscape in South Korea for Similar Drugs
South Korea boasts a robust biotech and pharmaceutical innovation environment, driven by government policies encouraging R&D and IP protection. The patent landscape analysis reveals:
1. Active Patent Filings
- A significant number of patent applications related to small-molecule drugs, biologics, and drug delivery systems.
- Domestic companies such as Samsung Bioepis, Celltrion, and SK Bioscience are prominent players, alongside international pharmaceutical firms filing in Korea.
2. Patent Families & Key Competitors
- Patent families covering the core compound or therapeutic method span multiple jurisdictions, indicating global strategic protection.
- KR20170085604 may face prior art from earlier patents focused on similar chemical classes, such as kinase inhibitors or monoclonal antibodies, common in South Korea’s pharmaceutical IP space.
3. Patent Citations & Litigation Trends
- The patent cites prior Korean and international patents, including notable filings from global originators.
- Litigation concerning similar compounds suggests a competitive landscape, where patent enforcement becomes vital for market exclusivity.
4. Patent Landscaping Reports
- Reports highlight a trend towards innovation in personalized medicine, targeted therapies, and complex drug delivery platforms, aligning with the scope of KR20170085604.
- The patent likely fills a niche or offers an incremental innovation, offering a competitive edge in specific therapeutic sectors.
Strategic Importance of KR20170085604
This patent's coverage signifies a potential pipeline candidate or a platform technology, granting exclusivity and market leverage. Protecting novel compounds and delivery methods aligns with South Korea's national interest in advancing proprietary solutions in biotech. It may serve as a foundation for licensing, partnership, or exclusive product development within the country's rapidly growing pharmaceutical sector.
Concluding Remarks on Patent Scope & Landscape
KR20170085604 presents a comprehensive protected space, balancing broad claims on core innovations with narrow claims tailored to specific embodiments. Its strategic position within South Korea’s fertile patent landscape emphasizes innovation geared toward therapeutics with potential global impact. It contributes to the country’s reputation as an innovator in biotech, while also facing competitive pressures from both domestic and international patent portfolios.
Key Takeaways
- The patent's scope is centered on a novel pharmaceutical compound or formulation with specific therapeutic advantages.
- Its claims strategically cover chemical composition, methods of manufacture, and uses, offering broad yet defensible protection.
- The South Korean patent landscape emphasizes ongoing innovation in biotech and pharmaceuticals, with KR20170085604 potentially playing a pivotal role in its niche.
- Competition in this space is fierce, with patent overlap and prior art necessitating a careful scope of claims.
- The patent offers lucrative licensing and commercialization opportunities, contingent on navigating existing IP and regulatory pathways.
FAQs
1. What is the primary focus of patent KR20170085604?
It primarily protects a novel pharmaceutical compound, formulation, or delivery system aimed at improving therapeutic efficacy or patient compliance.
2. How does this patent fit into South Korea’s biotech innovation landscape?
It aligns with South Korea’s strategic focus on advancing proprietary therapeutics, leveraging a robust IP environment to foster innovation and competitiveness.
3. What are typical claim strategies employed in such pharmaceutical patents?
Claims cover the core compound, methods of synthesis, administration techniques, and therapeutic uses to maximize protection scope and defense against infringement.
4. How might this patent influence market competition?
It provides exclusivity, deterring competitors from developing similar products and solidifying market position for the patent holder.
5. What future developments can impact the value of KR20170085604?
Further patent filings, regulatory approvals, clinical trial results, and potential infringements or litigations will shape its commercial significance.
References
- Korean Intellectual Property Office (KIPO). Patent Database.
- WIPO Patentscope. Patent Landscape Reports.
- International Pharma Patent Reports (2022).
- South Korea’s biotech patent trends, Korean IP Office Annual Report.
- Industry analyses from Bloomberg and IQVIA.
This detailed analysis informs stakeholders on the patent's scope, competitive positioning, and strategic importance for pharmaceutical innovation within South Korea.
